Therapies and Diagnostics for Cervical Cancer

Published - Aug 2013| Code - HLC141A| Analyst - Usha Nagavarapu

Report Highlights

The global cervical cancer market for drugs and diagnostics was $11.3 billion in 2012 and is expected to grow from $11.6 billion in 2013 to $15.6 billion by 2018, a compound annual growth rate (CAGR) of 6.1%.

Report Includes

  • An overview of the global market for cervical cancer diagnostics and therapies.
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • A breakdown of the markets by prophylactics, screening and diagnostics, surgery, radiation therapy, and drug therapy.
  • Discussion of cervical cancer biology.
  • Delineation of drugs approved to treat the disease, including chemotherapeutic and immunotherapeutic.
  • Evaluation of the patent landscape.
  • Comprehensive profiles of key companies.

SCOPE OF THE STUDY

The scope of this study includes testing, prophylactics vaccines, screening tests and methods, and therapeutics markets for cervical cancers. The report also discusses current technologies, new technologies, cervical cancer incidence, and market projections and market share, along with latest trends and new developments.

ABOUT THE AUTHOR

Usha Nagavarapu is an experienced pharmaceutical professional with scientific and business development experience. She has managed preclinical discovery programs involving target identification, including investigational new drug (IND) enabling studies, and assisted out-licensing and portfolio development activities. Her strong focus areas include oncology, dermatology, and cardiovascular diseases. She has extensive experience working with early start-ups to fulfill operational obligations while minimizing overall operational cost and burden.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
Title/Chapter Name Pages Price Member Price
Full Report: Therapies and Diagnostics for Cervical Cancer 211 $2,750 Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY2$250Free
Chapter- 3: OVERVIEW10$136Free
Chapter- 4: CERVICAL CANCER: BIOLOGY13$177Free
Chapter- 5: SCREENING22$300Free
Chapter- 6: THE TREATMENT OF CERVICAL CANCER14$191Free
Chapter- 7: CERVICAL CANCER INCIDENCE49$667Free
Chapter- 8: CERVICAL CANCER DIAGNOSTICS MARKET32$436Free
Chapter- 9: CERVICAL CANCER PROPHYLACTICS MARKET 11$150Free
Chapter- 10: THERAPEUTIC MARKET32$436Free
Chapter- 11: PATENT LANDSCAPE4$54Free
Chapter- 12: SELECTED COMPANY PROFILES9$123Free
RELATED REPORTS
Share This Report